Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
2003; Wiley; Volume: 86; Issue: 5 Linguagem: Inglês
10.1046/j.1471-4159.2003.01997.x
ISSN1471-4159
AutoresEtsuro Matsubara, Tara Bryant‐Thomas, Javier Pacheco, Tracey L. Henry, Burkhard Pöeggeler, Donald E. Herbert, Felix Cruz-Sánchez, Yau‐Jan Chyan, Mark A. Smith, George Perry, Daniel G. Chain, Eyal Neria, Mikio Shoji, Koji Abe, Anna Leone, Inge Grundke‐Iqbal, Glen L. Wilson, Jorge Ghiso, Christina Williams, Lorenzo M. Refolo, Miguel A. Pappolla,
Tópico(s)Genetics, Aging, and Longevity in Model Organisms
ResumoThe authors wish to make a correction to the above article that was published in J. Neurochem. 85, pp. 11011108. Authors Daniel G. Chain and Eyal Neria were omitted and this has been amended above. The authors also wish to acknowledge that this work has been supported by a NIA grant AG 16783 and by Mindset BioPharmaceuticals (USA) Inc.
Referência(s)